Wegovy

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

Not Just Weight Loss: 8 Conditions Drugs Like Wegovy Might Treat

Ozempic and Wegovy may help curb alcohol addiction, study suggests

Ozempic and Wegovy Ease Knee Osteoarthritis Pain in Large Study

Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study

Wegovy's Older Cousin Could Soon Be Sold Cheap. Here's How They Compare.

Does Semaglutide (Ozempic/Wegovy) Harm Your Mental Health? New Study Says No

Ozempic vs Wegovy: The Risks And Side Effects of Semaglutide Drugs

People Are Overdosing on Semaglutide Drugs like Ozempic and Wegovy

Ozempic and Wegovy could help people quit smoking

No More Nausea: New Discovery Could Reduce the Side Effects of Ozempic and Wegovy

Ozempic and Wegovy linked to lower risk of alcoholism

Genetic profile may predict best response to weight-loss drug Wegovy

Wegovy Can Keep Weight Off for at Least 4 Years, Research Shows

Weight loss from Wegovy sustained for up to four years, trial shows

You Quit Ozempic or Wegovy. What Happens Next?

Patients Hate ‘Forever’ Drugs. Are Ozempic and Wegovy Different?

Patients Hate ‘Forever’ Drugs. Are Ozempic and Wegovy Different?

Ozempic and Wegovy linked to a lower risk of cannabis use disorder

Wegovy Is First Weight-Loss Drug Approved for Heart Diseases

FDA Approves Wegovy For Heart Conditions in Game-Changing Move